Home Health Chirumhanzu teacher dies from ‘suspected’ Sinovac side effects

Chirumhanzu teacher dies from ‘suspected’ Sinovac side effects

by commuadmin
949 views

CommuTalk Reporter

CHIRUMHANZU:  A Chirumhanzu teacher stationed at Maware Primary School recently passed on after suffering side effects reportedly emanating from the Sinovac Covid-19 vaccine.

CommuTalk established that the now late Stephen Musvuti fell sick a day after receiving his first jab at Chengwena Clinic in Maware village.

To date, there is however no evidence that Musvuti died from the Covid-19 vaccine though family members indicate that they suspect he reacted from the dose since he fell ill soon after receiving the jab.

“The hand on which the jab was injected became swollen and his health progressively deteriorated. He was later referred to Hama Hospital for further management but he did not make it,” a close relative who preferred anonymity said.

“We expected to have explanations from a postmortem but nothing has been communicated to us as family to date. The other sad part is during burial we could not even conduct body viewing as word said his body continuously swelled and was not fit for the exercise.

“We are told police is conducting further investigations. We really look forward to results from the investigations as it would put our minds to rest,” added the family member.

Zimbabwe’s Ministry of Health has however advised that minor reactions minor reactions can occur after getting a vaccine such as a pain or swelling on injection site or a mild fever and irritability in children.

They also say these are usually indications that the vaccine has started to work and add that more serious side effects such as shock and persistent fever are possible, but extremely rare and vaccinators are trained to manage these.

Bloomberg reported in early March that fewer Hong Kong residents showed up to get vaccines from Chinese maker Sinovac Biotech Ltd amid reports of side effects, even as demand was strong for shots developed by Pfizer Inc.-BioNTech SE on the day of their debut.

You may also like

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More